Clostridium difficile is a major cause of nosocomial antibiotic-associated diarrhea [1]. Toxins A (enterotoxin; TcdA) and B (cytotoxin; TcdB) are well-known primary virulence factors of C. difficile [2]. These toxins are encoded by 2 separate genes, tcdA and tcdB, which are located 491 � Original Article• Clinical Microbiology � 491 491
INTRODUCTION
in the pathogenicity locus of the chromosome called PaLoc [3, 4] .
Toxigenic isolates of C. difficile usually produce both toxins A and B. Toxin A-negative and toxin B-positive (A -B + ) strains of C. difficile were first described in the early 1990s [5, 6] . A -B + strains fail to produce detectable amounts of toxin A due to a deletion in the repeating sequence of the tcdA gene. However, A -B + strains have been associated with clinical conditions ranging from asymptomatic carriage to fatal pseudomembranous colitis. Alfa et al. [7] reported convincing evidence that indicates that these strains have been responsible for outbreaks in hospitals.
Some isolates of C. difficile produce an additional binary toxin (actin-specific ADP-ribosyltransferase toxin, CDT), whose role in C. difficile-associated disease (CDAD) is unclear [8] . The 2 genes cdtA and cdtB encode the enzymatic (CDTa) and binding (CDTb) components of the binary toxin. These genes are located on the CDT locus of the chromosome but are not part of the PaLoc [8, 9] .
The prevalence of A -B + , and binary toxin-producing C.
difficile strains varies geographically [10] .
Recently, outbreaks of CDAD due to an emerging strain of C. difficile (PCR ribotype 027) associated with high morbidity and mortality have been reported in Canada, the United States, and Europe [11] . This strain produces a binary toxin and has deletions in tcdC, a putative negative regulator for toxins A and B [11, 12] . The epidemic strain is resistant to gatifloxacin and moxifloxacin, and increasing use of fluoroquinolone has been considered a risk factor in these outbreaks [11] . The most commonly used drugs for the treatment of CDAD are metronidazole (MTZ) and vancomycin (VAN). C. difficile is considered to be susceptible to both agents, and therefore, the in vitro activity of these agents against C. difficile isolates is rarely performed in most centers. However, a few reports have been published regarding elevated minimum inhibitory concentrations (MIC) of MTZ and VAN against C. difficile [13] . Moreover, increased resistance to antimicrobial agents has played a role in their selection in hospital environments [14] .
The objective of this study was to characterize clinical isolates of C. difficile associated with diarrhea throughout South Korea with regard to their toxin status, molecular typing, and antimicrobial susceptibility.
MATERALS AND METHODS

Bacterial strains
We obtained and analyzed 408 unduplicated isolates of 
Toxin analysis by PCR
C. difficile toxin genes were detected by PCR as described previously [15, 16] . The primer pairs used were NK9-NK11 for the repetitive domain of tcdA, NK104-NK105 for tcdB, cdtA pos-cdtA rev for cdtA, and cdtB pos-cdtB rev for cdtB.
PCR ribotyping
PCR ribotyping was performed as previously described with the primers 5′ -CTGGGGTGAAGTCGTAACAAGG-3′(position 1445 to 1466 of the 16S rRNA gene) and 5′ -GCGCCCTTTGTAGCTTGACC-3′(position 20 to 1 of the 23S rRNA gene) [17] . Comparison of the PCR ribotyping patterns was performed visually. Ribotype patterns that differed by at least 1 band were assigned to different types. Ribotype groups were designated by upper-and lower-case letters combined with a number.
tcdC sequencing
The tcdC gene was PCR-amplified with the primers PaL15 and PaL16 on the ribotype 027 strain as previously described [18] . Amplicons were sequenced commercially (Macrogen, Seoul, Korea). The analyzed amino acid sequences were compared to the published tcdC sequence for strain VPI10463 [18] .
Antimicrobial susceptibility testing
Antimicrobial susceptibility tests were performed with 120 C. difficile isolates using 10 randomly selected isolates per hospital and the agar dilution method on Brucella blood agar according to the recommendations of the CLSI [19] . Quality control strains used for susceptibility 
RESULTS
Toxin analysis by PCR
Of the total 408 isolates, 337 (82.6%) were toxigenic C. 
PCR ribotyping
A total of 50 different ribotype patterns were found.
We identified 24 patterns of A + B + CDTstrains (ribotype AB1-AB24), 12 A + B + CDT + (ribotype C1-C12), and 13 A -B -(ribotype ab1-ab13). The PCR ribotypes aB, C5, and C2 are equivalent to the PCR ribotypes 017, 027, and 078 by O' Neill' s method, respectively [17] (Fig. 1 ).
All A -B + strains showed the same banding pattern (ribotype aB) in ribotyping, which was identical to the pattern of the C. difficile 1470 strain (ribotype 017). Ribotype aB was the predominant type (105 isolates, 25.7%). 
Antimicrobial susceptibility testing
The in vitro activities of antimicrobial agents against C. difficile isolates are summarized in Table 2 . No isolates were susceptible to cefoxitin and all except 1 were susceptible to piperacillin and piperacillin-tazobactam.
The resistance rates to imipenem, cefotetan, moxifloxacin, ampicillin, and clindamycin were 25%, 34%, 42%, 51%, and 60%, respectively. All strains were susceptible to metronidazole and vancomycin.
DISCUSSION
We conducted this study to enhance the knowledge on the nationwide epidemiology of C. difficile. This study included data from 12 hospitals in 7 different areas of South Korea. [21] , and in another multicenter study conducted in Korea, 17.6-54.8% of the isolated strains were A -B + in 2005 [22] .
The prevalence of A -B + strains in Korea and Shanghai was much higher than in European countries.
The prevalence of CDT + strains was 7.1% (0-20.0%) in this study. Before the epidemics caused by ribotype 027, a binary toxin was identified in about 6% of clinical C.
difficile isolates obtained in the United States and Europe [16, 23] . The prevalence of CDT + C. difficile strains increased to 34.6% due to the ribotype 027 epidemics in Canada [24] .
In our previous study, the prevalence of CDT + strains increased from 0% in 2003 to 3.9% in 2006 [21] . Therefore, we thought the prevalence of CDT + strains had steadily increased without evidence of a C. difficile epidemic. All CDT + strains were A + B + . Therefore, no additional binary toxin test was required for the diagnosis of CDAD.
A total of 408 C. difficile isolates were successfully typed with our PCR ribotyping method. Predominant ribotypes among the participating hospitals were not significantly different.
All 105 A -B + strains showed the same ribotyping pattern (aB), which was the most common ribotype (105/408, 25.7%) and indistinguishable from the pattern of C. difficile 1470 (ribotype 017). It was previously reported that most A -B + strains yield this distinct ribotype pattern in many studies, suggesting a worldwide clonal spread [7, 10, 21] .
Only 1 PCR ribotype 027 strain was identified in hospital Seoul A. In contrast to epidemic 027 strains resistant to fluoroquinolone, this isolate was susceptible, which is in accordance with a report on 027 isolates obtained before 2001 in North America [11] .
PCR ribotype 078 is the predominant ribotype in calves and pigs, and is an emerging new hypervirulent strain [25] . [28, 29] . Therefore, the increased prevalence of A -B + strains in this study may reflect their higher MICs and the selective advantage it allows. This is the first nationwide study on the toxigenic status, including molecular genotyping and antimicrobial susceptibility pattern, of C. difficile isolates in South Korea. The prevalence of A -B + and CDT + strains was 25.7% and 7.1%, respectively. Surveys of all A -B + strains showed that the most common ribotype was ribotype 017. We isolated 1 ribotype 027 strain, which is regarded as a historic isolate, with susceptibility to moxifloxacin. The prevalence of ribotype 078 was 3.1%, which was higher than that of ribotype 027. We did not isolate strains with decreased susceptibility to MTZ or VAN, since these 2 antimicrobial agents can be used without an antimicrobial susceptibility test.
